Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Paediatric Drugs
|
June 1, 2007
A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study
Alexander Chuchalin, Eszter Csiszér, Kàlmàn Gyurkovics, et al.
Respiratory Medicine
|
May 16, 2008
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison
Stephen Rennard, Theo Bantje, Stefano Centanni, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
December 19, 2019
Scope and new horizons for implementation of m-Health/e-Health services in pulmonology in 2019
Vitaliy Mishlanov, Alexander Chuchalin, Valeriy Chereshnev, et al.
Pediatric Pulmonology
|
January 28, 2014
Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis
Henryk Mazurek, Raphaël Chiron, Tereza Kucerova, et al.
Drugs in Context
|
June 21, 2023
Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms
Mikhail Kostinov, Oksana Svitich, Alexander Chuchalin, et al.
Plos One
|
February 12, 2025
Clinical status and cytokine profiles in patients with asthma or chronic obstructive pulmonary disease vaccinated against influenza
Mikhail Kostinov, Alexander Chuchalin, Anna Chebykina, et al.
Scientific Reports
|
May 15, 2024
Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy
Mikhail Kostinov, Oksana Svitich, Alexander Chuchalin, et al.
Scientific Reports
|
March 11, 2025
Bacterial lysates in modifying sIgA levels in the upper respiratory tract in COVID-19 patients
Mikhail Kostinov, Alexander Chuchalin, Oksana Svitich, et al.
Current Pharmaceutical Design
|
March 20, 2014
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies
Jean Bousquet, Christian Jorgensen, Michel Dauzat, et al.
Nature Communications
|
March 13, 2014
Genome-wide association study reveals two new risk loci for bipolar disorder
Thomas W Mühleisen, Markus Leber, Thomas G Schulze, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Paediatric Drugs
|
June 1, 2007
A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study
Alexander Chuchalin, Eszter Csiszér, Kàlmàn Gyurkovics, et al.
Respiratory Medicine
|
May 16, 2008
A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison
Stephen Rennard, Theo Bantje, Stefano Centanni, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|
December 19, 2019
Scope and new horizons for implementation of m-Health/e-Health services in pulmonology in 2019
Vitaliy Mishlanov, Alexander Chuchalin, Valeriy Chereshnev, et al.
Pediatric Pulmonology
|
January 28, 2014
Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis
Henryk Mazurek, Raphaël Chiron, Tereza Kucerova, et al.
Drugs in Context
|
June 21, 2023
Changes in nasal, pharyngeal and salivary secretory IgA levels in patients with COVID-19 and the possibility of correction of their secretion using combined intranasal and oral administration of a pharmaceutical containing antigens of opportunistic microorganisms
Mikhail Kostinov, Oksana Svitich, Alexander Chuchalin, et al.
Plos One
|
February 12, 2025
Clinical status and cytokine profiles in patients with asthma or chronic obstructive pulmonary disease vaccinated against influenza
Mikhail Kostinov, Alexander Chuchalin, Anna Chebykina, et al.
Scientific Reports
|
May 15, 2024
Secretory IgA and course of COVID-19 in patients receiving a bacteria-based immunostimulant agent in addition to background therapy
Mikhail Kostinov, Oksana Svitich, Alexander Chuchalin, et al.
Scientific Reports
|
March 11, 2025
Bacterial lysates in modifying sIgA levels in the upper respiratory tract in COVID-19 patients
Mikhail Kostinov, Alexander Chuchalin, Oksana Svitich, et al.
Current Pharmaceutical Design
|
March 20, 2014
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies
Jean Bousquet, Christian Jorgensen, Michel Dauzat, et al.
Nature Communications
|
March 13, 2014
Genome-wide association study reveals two new risk loci for bipolar disorder
Thomas W Mühleisen, Markus Leber, Thomas G Schulze, et al.
Page
of 3